Richard E. Gray

2.0k total citations
56 papers, 1.4k citations indexed

About

Richard E. Gray is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Richard E. Gray has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Rheumatology. Recurrent topics in Richard E. Gray's work include Bone health and treatments (11 papers), Medical Imaging and Pathology Studies (6 papers) and Bone and Joint Diseases (4 papers). Richard E. Gray is often cited by papers focused on Bone health and treatments (11 papers), Medical Imaging and Pathology Studies (6 papers) and Bone and Joint Diseases (4 papers). Richard E. Gray collaborates with scholars based in United Kingdom, United States and Australia. Richard E. Gray's co-authors include John А. Kanis, Anthony R. Cashmore, A.J.P. Yates, Marita Broadhurst, Richard Percival, M.N.C. Benéton, Neveen A. T. Hamdy, C.J. Preston, R.G.G. Russell and G.H. Urwin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Molecular Biology.

In The Last Decade

Richard E. Gray

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard E. Gray United Kingdom 21 547 389 363 238 181 56 1.4k
S Bianchi Italy 22 398 0.7× 366 0.9× 289 0.8× 100 0.4× 202 1.1× 54 2.0k
John McClure United Kingdom 21 445 0.8× 194 0.5× 488 1.3× 219 0.9× 440 2.4× 83 1.6k
Shigeru Ohno Japan 23 124 0.2× 429 1.1× 202 0.6× 79 0.3× 792 4.4× 127 2.0k
J Cervenka United States 28 361 0.7× 1.4k 3.7× 120 0.3× 66 0.3× 304 1.7× 79 3.0k
P. Vaith Germany 24 101 0.2× 333 0.9× 701 1.9× 51 0.2× 700 3.9× 68 1.8k
Benjamin Klein Israel 22 273 0.5× 464 1.2× 58 0.2× 101 0.4× 100 0.6× 96 1.4k
G.N. Kent Australia 25 782 1.4× 463 1.2× 184 0.5× 593 2.5× 219 1.2× 60 1.8k
J. E. Wergedal United States 30 650 1.2× 1.2k 3.2× 59 0.2× 839 3.5× 386 2.1× 54 2.7k
Mustafa Turan Türkiye 25 162 0.3× 282 0.7× 118 0.3× 109 0.5× 170 0.9× 112 1.8k
Yuko Takahashi Japan 25 204 0.4× 289 0.7× 433 1.2× 67 0.3× 650 3.6× 145 2.1k

Countries citing papers authored by Richard E. Gray

Since Specialization
Citations

This map shows the geographic impact of Richard E. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Gray more than expected).

Fields of papers citing papers by Richard E. Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Gray. The network helps show where Richard E. Gray may publish in the future.

Co-authorship network of co-authors of Richard E. Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Gray. A scholar is included among the top collaborators of Richard E. Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Gray. Richard E. Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seité, Paule, Richard E. Gray, Justin P. Ludeman, et al.. (2009). GHTD-amide: A naturally occurring beta cell-derived peptide with hypoglycemic activity. Peptides. 30(5). 955–961. 5 indexed citations
2.
Lawrenson, Ross, et al.. (2005). PIXI bone density screening for osteoporosis in postmenopausal women. Maturitas. 53(3). 245–251. 1 indexed citations
3.
Brennan, Paul, et al.. (1996). Paget's disease of bone and unvaccinated dogs. Bone. 19(1). 47–50. 34 indexed citations
4.
Gray, Richard E., et al.. (1994). A CLINICAL, SEROLOGICAL AND NEUROPHYSIOLOGICAL STUDY OF RESTLESS LEGS SYNDROME IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 33(1). 60–63. 84 indexed citations
5.
Hawkins, Philip N., Sylvia Richardson, David M. Vigushin, et al.. (1993). Serum amyloid p component scintigraphy and turnover studies for diagnosis and quantitative monitoring of aa amyloidosis in juvenile rheumatoid arthritis. Arthritis & Rheumatism. 36(6). 842–851. 68 indexed citations
6.
Gray, Richard E., Sheelagh Doherty, John A Galloway, et al.. (1991). A double‐blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis & Rheumatism. 34(3). 287–295. 63 indexed citations
7.
Gray, Richard E., Elizabeth A. Jenkins, M A Hall, Jack J. Kanski, & B M Ansell. (1989). Recurrent acute proptosis in atypical systemic lupus erythematosus. Clinical Rheumatology. 8(4). 528–532. 6 indexed citations
8.
Gray, Elmer & Richard E. Gray. (1987). Observations on popcorn disease of mulberry in south central kentucky usa. Castanea. 52(1). 47–51. 10 indexed citations
9.
Gray, Richard E., A. John Yates, C.J. Preston, et al.. (1987). Duration of Effect of Oral Diphosphonate Therapy in Paget's Disease of Bone. QJM. 58 indexed citations
10.
Atkins, Roger M., Richard E. Gray, G.H. Urwin, et al.. (1987). Aminohexane diphosphonate in the treatment of paget' s disease of bone. Journal of Bone and Mineral Research. 2(4). 273–279. 41 indexed citations
11.
Preston, C.J., A.J.P. Yates, M.N.C. Benéton, et al.. (1986). Effective short term treatment of Paget's disease with oral etidronate.. BMJ. 292(6513). 79–80. 29 indexed citations
12.
Percival, Richard, A.J.P. Yates, Richard E. Gray, et al.. (1985). Mechanism of malignant hypercalcaemia in carcinoma of the breast.. BMJ. 291(6498). 776–779. 79 indexed citations
13.
Percival, Richard, A.J.P. Yates, Richard E. Gray, et al.. (1984). Role of glucocorticoids in management of malignant hypercalcaemia.. BMJ. 289(6440). 287–287. 47 indexed citations
14.
Drnevich, Vincent P. & Richard E. Gray. (1981). Acoustic emissions in geotechnical engineering practice : a symposium. 1 indexed citations
15.
Chaux, Aurelio & Richard E. Gray. (1980). St. Jude Medical prosthesis. Journal of Thoracic and Cardiovascular Surgery. 80(5). 800–800. 1 indexed citations
16.
Gray, Richard E., et al.. (1977). Processes of colluvial slope development at MC Mechen, west Virginia. Bulletin of Engineering Geology and the Environment. 16(1). 29–32. 6 indexed citations
17.
Gray, Richard E., et al.. (1977). Study and analysis of surface subsidence over the mined Pittsburgh coalbed. Open file report. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 17(2). 64–64. 2 indexed citations
18.
Gray, Richard E.. (1973). Replacement name for Haywardina Forster, 1964 (Lepidoptera: Satyridae). Biodiversity Heritage Library (Smithsonian Institution). 5 indexed citations
19.
Gray, Richard E.. (1958). A comparison between MacConkey broth and glutamic acid media for the detection of coliform organisms in water. Journal of Hygiene. 56(3). 377–388. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026